HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis. Mazdeh M, Taheri M, Sayad A, Bahram S, Omrani M D, Movafagh A, Inoko H, Akbari M T, Noroozi R, Hajilooi M, et al. Pharmacogenomics. 2016 Mar 29. PMID: 27020477. Abstract CommentRecommendBookmarkWatch